June 18, 2024
Gibson, Dunn & Crutcher advised EQT on the acquisition of a majority stake in CluePoints, with meaningful reinvestment from the management team and existing shareholders.
This investment in CluePoints – a premier cloud-based software platform for Risk-Based Quality Management and data quality oversight in clinical trials – is aligned with EQT’s objective of supporting companies with their mission to deliver positive healthcare outcomes and to invest in the next generation of technology leaders.
The Gibson Dunn team advising EQT was led by European Co-chair of Private Equity Wim De Vlieger, and comprised counsel Jakob Egle, of counsel Cason Moore and associates Joanne Hughes, Rosie Maguire and Leonnie Gilpin (Corporate, London). The team also included partner Sandy Bhogal and associate Bridget English (Tax, London).